Endpoints for clinical trials in young children with cystic fibrosis

Proceedings of the American Thoracic Society

Volumn 4, Issue 4, 2007, Pages 418-430

  Davis, Stephanie D ^a   Brody, Alan S ^b   Emond, Mary J ^c   Brumback, Lyndia C ^c   Rosenfeld, Margaret ^d,e  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Bronchoalveolar lavage; Child; Computed tomography scanners; Infant; Preschool; Respiratory function tests; X ray

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; TOBRAMYCIN;

ANTIBIOTIC THERAPY; CHILDHOOD; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CYSTIC FIBROSIS; DISEASE EXACERBATION; GRAM NEGATIVE INFECTION; HUMAN; LUNG DISEASE; LUNG FUNCTION TEST; LUNG LAVAGE; OUTCOME ASSESSMENT; PLETHYSMOGRAPHY; POPULATION RESEARCH; PROGNOSIS; PSEUDOMONAS AERUGINOSA; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SPIROMETRY; THORAX RADIOGRAPHY;

CHILD, PRESCHOOL; CLINICAL TRIALS; CYSTIC FIBROSIS; HUMANS; INFANT; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; RADIOGRAPHY, THORACIC; REPRODUCIBILITY OF RESULTS; RESPIRATORY FUNCTION TESTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34548224990     PISSN: 15463222     EISSN: None     Source Type: Journal    
DOI: 10.1513/pats.200703-041BR     Document Type: Conference Paper

References (127)

1. Hammer J, Eber E, editors. Paediatric pulmonary function testing. Basel: Karger; 2005.
2. Gappa M, Ranganathan S, Stocks J. Lung function testing in infants with cystic fibrosis: lessons from the past and future directions. Pediatr Pulmonol 2001;32:228-245.
3. Beardsmore CS, Bar-Yishay E, Maayan C, Yahav Y, Katznelson D, Godfrey S. Lung function in infants with cystic fibrosis. Thorax 1988;43:545-551.
4. Tepper RS, Montgomery GL, Ackerman V, Eigen H. Longitudinal evaluation of pulmonary function in infants and very young children with cystic fibrosis. Pediatr Pulmonol 1993;16:96-100.
5. Tepper RS, Hiatt P, Eigen H, Scott P, Grosfeld J, Cohen M. Infants with cystic fibrosis: pulmonary function at diagnosis. Pediatr Pulmonol 1988;5:15-18.
6. Clayton RG Sr, Diaz CE, Bashir NS, Panitch HW, Schidlow DV, Allen JL. Pulmonary function in hospitalized infants and toddlers with cystic fibrosis. J Pediatr 1998;132:405-408.
7. Tepper RS, Eigen H, Stevens J, Angelicchio C, Kisling J, Ambrosius W, Heilman D. Lower respiratory illness in infants and young children with cystic fibrosis: evaluation of treatment with intravenous hydrocortisone. Pediatr Pulmonol 1997;24:48-51.
8. Maayan C, Bar-Yishay E, Yaacobi T, Marcus Y, Katznelson D, Yahav Y, Godfrey S. Immediate effect of various treatments on lung function in infants with cystic fibrosis. Respiration (Herrlisheim) 1989;55:144-151.
9. Hiatt PW, Grace SC, Kozinetz CA, Raboudi SH, Treece DG, Taber LH, Piedra PA. Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis. Pediatrics 1999;103:619-626.
10. Allen JL, Bar-Yishay E, Bryan AC, Budd J, Castile RG, Coates AL, Davis GM, England S, Gaultier C, Godfrey S, et al. Respiratory mechanics in infants: physiologic evaluation in health and disease. Am Rev Respir Dis 1993;147:474-496.
11. Turner DJ, Lanteri CJ, LeSouef PN, Sly PD. Improved detection of abnormal respiratory function using forced expiration from raised lung volume in infants with cystic fibrosis. Eur Respir J 1994;7:1995-1999.
12. Davis S, Jones M, Kisling J, Howard J, Tepper R. Comparison of normal infants and infants with cystic fibrosis using forced expiratory flows breathing air and heliox. Pediatr Pulmonol 2001;31:17-23.
13. Ranganathan S, Bush A, Dezateux C, Carr S, Hoo A, Lum S, Madge S, Price J, Stroobant J, Wade A, et al.; London Collaborative Cystic Fibrosis Group. Relative ability of full and partial forced expiratory maneuvers to identify diminished airway function in infants with cystic fibrosis. Am J Respir Crit Care Med 2002;166:1350-1357.
14. Ranganathan SC, Stocks J, Dezateux C, Bush A, Wade A, Carr S, Castle R, Dinwiddie R, Hoo AF, Lum S, et al.; London Collaborative Cystic Fibrosis Group. The evolution of airway function in early childhood following clinical diagnosis of cystic fibrosis. Am J Respir Crit Care Med 2004;169:928-933.
15. Ranganathan SC, Dezateux C, Bush A, Carr SB, Castle RA, Madge S, Price J, Stroobant J, Wade A, Wallis C, et al.; London Collaborative Cystic Fibrosis Group. Airway function in infants newly diagnosed with cystic fibrosis. Lancet 2001;358:1964-1965.
16. Lum, S, Gustafsson P, Ljungberg H, Hulskmap G, Bush A, Siobhan BC, Castle R, Hoo A-F, Price J, Ranganathan S, et al. Early detection of cystic fibrosis lung disease: multiple-breath washout vs. raised-volume tests. Thorax 2007;62:341-347.
17. Castile RG, Durdana I, McCoy K. Gas trapping in normal infants and in infants with cystic fibrosis. Pediatr Pulmonol 2004;37:461-469.
18. Davis S, Kerby G, Acton J, Castile R, Colin A, Conrad C, Hart M, Hiatt P, Mogayzel P, Johnson R, et al. Feasibility, sensitivity and variability of adult-type pulmonary function tests in infants with CF in a multicenter, longitudinal trial. Pediatr Pulmonol 2006;(Suppl 29):A360.
19. Phelan PD, Gracey M, Williams HE, Anderson CM. Ventilatory function in infants with cystic fibrosis: physiological assessment of inhalation therapy. Arch Dis Child 1969;44:393-400.
20. Dakin CJ, Numa AH, Wang HE, Morton JR, Vertzysa CC, Henry RL. Inflammation, infection and pulmonary function in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 2002;165:904-910.
21. Sheikh, Flucke R, McCoy K, Castile R. Changes in lung function during treatment for pulmonary exacerbations in infants with cystic fibrosis. Pediatr Pulmonol 2000;(Suppl 20):A429.
22. Rosenfeld M, Gibson RL, McNamara S, Emerson J, Burns JL, Castile R, Hiatt P, McCoy K, Wilson CB, Inglis A, et al. Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol. 2001;32:356-366.
23. Godfrey S, Mearns M, Howlett G. Serial lung function studies in cystic fibrosis in the first 5 years of life. Arch Dis Child 1978;53:83-85.
24. Lanteri CJ, Raven JM, Sly PD. Should TGV be measured from end-inspiratory occlusions rather than end-expiratory occlusions in wheezy infants? Pediatr Pulmonol 1990;9:214-219.
25. Beardsmore CS, Stocks J, Silverman M. Problems in measurement of thoracic gas volume in infancy. J Appl Physiol 1982;52:995-999.
26. McCoy KS, Castile RG, Allen ED, Filbrun DA, Flucke RL, Bar-Yishay E. Functional residual capacity (FRC) measurements by plethysmography and helium dilution in normal infants. Pediatr Pulmonol 1995;19:282-290.
27. Helms P. Problems with plethysmographic estimation of lung volume in infants and young children. J Appl Physiol 1982;53:698-702.
28. Gustafsson PM, Ljungberg H. Measurement of functional residual capacity and ventilation inhomogeneity by gas dilution techniques: pediatric pulmonary function testing. Prog Respir Res 2005;33:54-65.
29. American Thoracic Society; European Respiratory Society. The ATS/ ERS Working Group on Infant and Young Children Pulmonary Function Testing Consensus Statement. Raised volume forced expirations in infants: guidelines for current practice. Am J Respir Crit Care Med 2005;172:1463-1471.
30. Castile RG, Filbrun D, Flucke R, Franklin W, McCoy K. Adult-type pulmonary function tests in infants without respiratory disease. Pediatr Pulmonol 2000;30:215-227.
31. Gappa M, Fletcher M, Dezateux C, Stocks J. Comparison of nitrogen washout and plethysmographic measurements of lung volume in healthy infants. Am Rev Respir Dis 1993;148:1496-1501.
32. Gustafsson PM, Kallmann S, Ljungberg H, Lindblad A. Method for assessment of volume of trapped gas in infants during multiple-breath inert gas washout. Pediatr Pulmonol 2003;35:42-49.
33. Schibler A, Schneider M, Frey U, Kraemer R. Moment ratio analysis of multiple breath nitrogen washout in infants with lung disease. Eur Respir J 2000;15:1094-1101.
34. Aurora P, Bush A, Gustafsson P, Oliver C, Wallis C, Price J, Stroonbant J, Carr S, Stocks J. Multiple-breath washout as a marker of lung disease in preschool children with cystic fibrosis. Am J Respir Crit Care Med 2005;171:249-256.
35. Hanrahan JP, Tager IB, Castile RG, Segal MR, Weiss ST, Speizer FE. Pulmonary function measures in healthy infants: variability and size correction. Am Rev Respir Dis 1990;141:1127-1135.
36. Hoo AF, Dezateux C, Hanrahan JP, Cole TJ, Tepper RS, Stocks J. Sex-specific prediction equations for Vmax(FRC) in infancy: a multicenter collaborative study. Am J Respir Crit Care Med 2002;165:1084-1092.
37. Jones M, Castile R, Davis S, Kisling J, Filbrun D, Flucke R, Goldstein A, Emsley C, Ambrosius W, Tepper RS. Forced expiratory flows and volumes in infants normative data and lung growth. Am J Respir Crit Care Med 2000;161:353-359.
38. Stocks J, Quanjer PH. Reference values for residual volume functional residual capacity and total lung capacity. Eur Respir J 1995;8:492-506.
39. Stocks J, Marchal F, Kraemer R, Gutkowski P, Bar-Yishay E, Godfrey S. Plethysmographic assessment of functional residual capacity and airway resistance. In: Stocks J, Sly PD, Tepper RS, Morgan WJ, editors. Infant respiratory function testing. New York: John Wiley & Sons; 1996. pp. 190-240.
40. Hulskamp G, Hoo A, Ljungberg H, Lum S, Pillow J, Stocks J. Progressive decline in plethysmographic lung volumes in infants. Am J Respir Crit Care Med 2003;168:1003-1009.
41. Ranganathan S, Hoo A, Lum S, Goetz I, Castle R, Stocks J. Exploring the relationship between forced maximal flow at functional residual capacity and parameters of forced expiration from raised lung volume in healthy infants. Pediatr Pulmonol 2002;33:419-428.
42. Turner DJ, Stick SM, Lesouef KL, Sly PD, Lesouef PN. A new technique to generate and assess forced expiration from raised lung volume in infants. Am J Respir Crit Care Med 1995;151:1441-1450.
43. Stocks J, Godfrey S, Beardsmore C, Bar-Yishay E, Castile R, for the ERS/ATS Task Force on Standards for Infant Respiratory Function Testing. Plethsymographic measurements of lung volume and air resistance. Eur Respir J 2001;17:302-312.
44. Morris MG, Gustafsson P, Tepper R, Gappa M, Stocks J, for the ERS/ ATS Task Force on Standards for Infant Respiratory Function Testing. The bias flow nitrogen washout technique for measuring the functional residual capacity in infants. Eur Respir J 2001;17:529-536.
45. Sly PD, Tepper R, Henschen M, Gappa M, Stocks J, for the ERS/ATS Task Force on Standards for Infant Respiratory Function Testing. Tidal forced expirations. Eur Respir J 2000;16:741-748.
46. Gaultier C, Fletcher M, Beardsmore C, Motoyama E, Stocks J. Measurement conditions. In: Stocks J, Sly PD, Tepper RS, Morgan WJ, editors. Infant respiratory function testing. New York: Wiley; 1996. pp. 29-44.
47. Beydon N, Davis S, Lombardi E, Allen JL, Aurora P, Bisgaard H, Davis M, Ducharme F, Eigen H, Gappa M, et al. An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children. Am J Respir Crit Care Med 2007;175:1304-1345.
48. Davis SD. Neonatal and pediatric respiratory diagnostics. Respir Care 2003;8:367-384.
49. Eigen H, Bieler H, Grant D, Christoph K, Terrill D, Heilman DK, Ambrosius WT, Tepper RS. Spirometric pulmonary function in healthy preschool children. Am J Respir Crit Care Med 2001;163:619-623.
50. Vilozni D, Barker M, Jellouschek H, Heimann G, Blau H. An interactive computer-animated system (SpiroGame) facilitates spirometry in preschool children. Am J Respir Crit Care Med 2001;164:2200-2205.
51. Vilozni D, Barak A, Efrati O, Augarten A, Springer C, Yacov Y, Bentur L. The role of computer games in measuring spirometry in healthy and "asthmatic" preschool children. Chest 2005;128:1146-1155.
52. Kanengiser S, Dozer A. Forced expiratory maneuvers in children ages 3 to 5 years. Pediatr Pulmonol 1994;18:144-149.
53. Crenesse D, Berlioz M, Bourrier T, Albertini M. Spirometry in children aged 3-5 years: reliability of forced expiratory maneuvers. Pediatr Pulmonol 2002;32:56-61.
54. Nystad W, Samuelsen SO, Nafstad P, Edvardsen E, Stensrud T, Jaakkola JJK. Feasibility of measuring lung function in preschool children. Thorax 2002;57:1021-1027.
55. Zapletal A, Chalupova J. Forced expiratory parameters in healthy preschool children (3-6 years of age). Pediatr Pulmonol 2003;35:200-207.
56. Aurora P, Stocks J, Oliver C, Saunders C, Castle R, Chaziparasidis G, Bush A. Quality control for spirometry in preschool children with and without lung disease. Am J Respir Crit Care Med 2004;169:1152-1159.
57. Davis S. Preschool spirometry. Pediatr Respir Rev 2006;7:S11-S13.
58. Lombardi E, Sly PD, Concutelli G, Novembre E, Veneruso G, Frongia G, Bernardini R, Vierucci A. Reference values of interrupter respiratory resistance in healthy preschool white children. Thorax 2001;56:691-695.
59. Merkus PJFM, Mijnsbergen JY, Hop WCJ, de Jongste JC. Interrupter resistance in preschool children: measurement characteristics and reference values. Am J Respir Crit Care Med 2001;163:1350-1355.
60. Bridge PD, Ranganathan S, McKenzie SA. Measurement of airway resistance using the interrupter technique in preschool children in the ambulatory setting. Eur Respir J 1999;3:792-796.
61. Beydon N, Amsallem F, Bellet M, Boule M, Chaussain M, Denjean A, Matran R, Wuyam B, Alberti C, Gaultier C; French Pediatric Programme Hospitalier de Recherche Clinique Group. Pre/postbronchodilator interrupter resistance values in healthy young children. Am J Respir Crit Care Med 2002;165:1388-1394.
62. Beydon N, Amsallem F, Bellet M, Boule M, Chaussain M, Denjean A, Matran R, Pin I, Alberti C, Gaultier C. Pulmonary function tests in preschool children with cystic fibrosis. Am J Respir Crit Care Med 2002;166:1099-1104.
63. Beydon N, Pin I, Matran R, Chaussain M, Boule M, Alain B, Bellet M, Amasallem F, Alberti C, Denjean A, et al. Pulmonary function tests in preschool children with asthma. Am J Respir Crit Care Med 2003;168:640-644.
64. Desager K, Marchal F, Van de Woestijne K. Forced oscillation technique. In: Stocks J, Sly PD, Tepper RS, Morgan WJ, editors. Infant respiratory function testing. New York: John Wiley and Sons; 1996. pp. 355-378.
65. Johnson B, Beck K, Zeballos J, Weisman I. Global theme issue: emerging technology in clinical medicine: advances in pulmonary laboratory testing. Chest 1999;116:1377-1386.
66. Navajas D, Farre R. Forced oscillation technique: from theory to clinical applications. Monaldi Arch Chest Dis 2001;56:555-562.
67. Ducharme FM, Davis GM, Ducharme GR. Pediatric reference values for respiratory resistance measured by forced oscillation. Chest 1998;113:1322-1328.
68. Duiverman EJ, Clement J, van de Woestijne KP, Neijens HJ, van den Bergh ACM, Kerrebijn KF. Forced oscillation technique: reference values for resistance and reactance over a frequency spectrum of 2-26 Hz in healthy children aged 2.3-12.5 years. Bull Eur Physiopathol Respir 1985;21:171-178.
69. Mazurek H, Willim G, Marchal FHJ, Tomalak W. Input respiratory impedance measured by head generator in preschool children. Pediatr Pulmonol 2000;30:47-55.
70. Klug B, Bisgaard H. Specific airway resistance, interrupter resistance, and respiratory impedance in healthy children aged 2-7 years. Pediatr Pulmonol 1998;25:322-331.
71. Malmberg LP, Pelkonen A, Poussa T, Pohianpalo A, Haahtela T, Turpeinen M. Determinants of respiratory system input impedance and bronchodilator response in healthy Finnish preschool children. Clin Physiol Funct Imaging 2002;22:64-71.
72. Guilbert TW, Morgan WJ, Zeiger RS, Mauger DT, Boehmer SJ, Szefler SJ, Bacharier LB, Lemanske RF Jr, Strunk RC, Allen DB, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006;354:1985-1997.
73. Bisgaard H, Nielsen KG. Plethysmographic measurements of specific airway resistance in young children. Chest 2005;128:355-362.
74. Nielsen KG, Bisgaard H. Cold air challenge and specific airway resistance in preschool children. Paediatr Respir Rev 2005;6:255-266.
75. Nielsen KG. Plethysmographic specific airway resistance. Paediatr Respir Rev 2006;7S:S17-S19.
76. Aurora P. Multiple-breath washout in preschool children: FRC and ventilation inhomogeneity. Paediatr Respir Rev 2006;7S:S14-S16.
77. Marostica PJ, Weist AD, Eigen H, Angelicchio C, Christoph K, Savage J, Grant D, Tepper RS. Spirometry in 3- to 6-year-old children with cystic fibrosis. Am J Respir Crit Care Med 2002;166:67-71.
78. Vilozni D, Bentur L, Efrati O, Minuskin T, Barak A, Szeinberg A, Blau H, Picard E, Kerem E, Yahav Y, et al. Spirometry in early childhood in cystic fibrosis patients. Chest 2007;131:356-361.
79. Nielsen KG, Pressler T, Klug B, Koch C, Bisgaard H. Serial lung function and responsiveness in cystic fibrosis during early childhood. Am J Respir Crit Care Med 2004;169:1209-1216.
80. Brennan S, Hall GL, Horak F, Moeller A, Pitrez PM, Franzmann A, Turner S, de Klerk N, Franklin P, Winfield KR, et al. Correlation of forced oscillation technique in preschool children with cystic fibrosis with pulmonary inflammation. Thorax 2005;60:159-163.
81. Lowe L, Murray CS, Custovic A, Simpson BM, Kissen PM, Woodcock A. Specific airway resistance in 3-year-old children: a prospective cohort study. Lancet 2002;359:1904-1908.
82. Chan EY, Bridge PD, Dundas I, Pao CS, Healy MJ, McKenzie SA. Repeatability of airway resistance measurements made using the interrupter technique. Thorax 2003;58:344-347.
83. Slattery DM, Zurakowski D, Colin AA, Cleveland RHCF. An X-ray database to assess effect of aerosolized tobramycin. Pediatr Pulmonol 2004;38:23-30.
84. Puderbach, M, Eichinger, M, Gahr, J, Ley, S, Tuengerthal, S, Schmahl, A, Fink, C, Plathow, C, Wiebel, M, Muller, FM, Kauczor, HU. Proton MRI appearance of cystic fibrosis: comparison to CT. Eur Radiol 200717:716-724.
85. van Beek EJ, Hill C, Woodhouse N, Fichele S, Fleming S, Howe B, Bott S, Wild JM, Taylor CJ. Assessment of lung disease in children with cystic fibrosis using hyperpolarized 3-helium MRI: comparison with Shwachman score, Chrispin-Norman score and spirometry. Eur Radiol 2007;17:1018-1024.
86. Chen DL, Ferkol TW, Mintun MA, Pittman JE, Rosenbluth DB, Schuster DP. Quantifying pulmonary inflammation in cystic fibrosis with positron emission tomography. Am J Respir Crit Care Med 2006;173:1363-1369.
87. Frush DP. Review of radiation issues for computed tomography. Semin Ultrasound CT MR 2004;25:17-24.
88. Coddington R, Mera SL, Goddard PR, Bradfield JW. Pathological evaluation of computed tomography images of lungs. J Clin Pathol 1982;35:536-540.
89. Long FR, Williams RS, Castile RG. Structural airway abnormalities in infants and young children with cystic fibrosis. J Pediatr 2004;144:154-161.
90. Tiddens HAWM, Rosenfeld M, Brody AS, editors. Symposium: Imaging endpoints for cystic fibrosis clinical trials. Proc Am Thorac Soc 2007;4:295-363.
91. Long FR, Castile RG, Brody AS, Hogan MJ, Flucke RL, Filbrun DA, McCoy KS. Lungs in infants and young children: improved thinsection CT with a noninvasive controlled-ventilation technique-initial experience. Radiology 1999;212:588-593.
92. Robinson TE, Leung AN, Moss RB, Blankenberg FG, al-Dabbagh H, Northway WH. Standardized high-resolution CT of the lung using a spirometer-triggered electron beam CT scanner. AJR Am J Roentgenol 1999;172:1636-1638.
93. de Jong PA, Ottink MD, Robben SG, Lequin MH, Hop WC, Hendriks JJ, Pare PD, Tiddens HA. Pulmonary disease assessment in cystic fibrosis: comparison of CT scoring systems and value of bronchial and arterial dimension measurements. Radiology 2004;231:434-439.
94. Brody AS, Kosorok MR, Li Z, Broderick LS, Foster JL, Laxova A, Bandla H, Farrell PM. Reproducibility of a scoring system for computed tomography scanning in cystic fibrosis. J Thorac Imaging 2006;21:14-21.
95. de Jong PA, Nakano Y, Hop WC, Long FR, Coxson HO, Pare PD, Tiddens HA. Changes in airway dimensions on computed tomography scans of children with cystic fibrosis. Am J Respir Crit Care Med 2005;172:218-224.
96. Robinson TE, Leung AN, Northway WH, Blankenberg FG, Bloch DA, Oehlert JW, Al-Dabbagh H, Hubli S, Moss RB. Spirometer-triggered high-resolution computed tomography and pulmonary function measurements during an acute exacerbation in patients with cystic fibrosis. J Pediatr 2001;138:553-559.
97. Bonnel AS, Song SM, Kesavarju K, Newaskar M, Paxton CJ, Bloch DA, Moss RB, Robinson TE. Quantitative air-trapping analysis in children with mild cystic fibrosis lung disease. Pediatr Pulmonol 2004;38:396-405.
98. Robinson TE, Goris ML, Zhu HJ, Chen X, Bhise P, Sheikh F, Moss RB. Dornase alfa reduces air trapping in children with mild cystic fibrosis lung disease: a quantitative analysis. Chest 2005;128:2327-2335.
99. Donnelly LF, Frush DP. Pediatric multidetector body CT. Radiol Clin North Am 2003;41:637-655.
100. Egelhoff JC, Ball WS Jr, Koch BL, Parks TD. Safety and efficacy of sedation in children using a structured sedation program. AJR Am J Roentgenol 1997;168:1259-1262.
101. Long FR, Williams RS, Adler BH, Castile RG. Comparison of quiet breathing and controlled ventilation in the high-resolution CT assessment of airway disease in infants with cystic fibrosis. Pediatr Radiol 2005;35:1075-1080.
102. Davis SD, Fordham LA, Brody AS, Noah TL, Retsch-Bogart GZ, Qaqish BF, Yankaskas BC, Johnson RC, Leigh MW. Computed tomography reflects lower airway inflammation and tracks changes in early cystic fibrosis. Am J Respir Crit Care Med 2007;175:943-950.
103. Nasr SZ, Kuhns LR, Brown RW, Hurwitz ME, Sanders GM, Strouse PJ. Use of computerized tomography and chest X-rays in evaluating efficacy of aerosolized recombinant human DNase in cystic fibrosis patients younger than age 5 years: a preliminary study. Pediatr Pulmonol 2001;31:377-382.
104. de Jong PA, Long FR, Nakano Y. Computed tomography dose and variability of airway dimension measurements: how low can we go? Pediatr Radiol 2006;36:1043-1047.
105. Long FR, Williams RS, Castile RG. Inspiratory and expiratory CT lung density in infants and young children. Pediatr Radiol 2005;35:677-683.
106. Pocock SJ, Geller NL, Tsiatis AA. The analysis of multiple endpoints in clinical trials. Biometrics 1987;43:487-498.
107. Heitjan DF. Ignorability and coarse data: some biomedical examples. Biometrics 1993;49:1099-1109.
108. Brody AS, Klein JS, Molina PL, Quan J, Bean JA, Wilmott RW. High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests. J Pediatr 2004;145:32-38.
109. Thomassen MJ, Klinger JD, Badger SJ, van Heeckeren DW, Stern RC. Cultures of thoracotomy specimens confirm usefulness of sputum cultures in cystic fibrosis. J Pediatr 1984;104:352-356.
110. Jung A, Kleinau I, Schonian G, Bauernfeind A, Chen C, Griese M, Doring G, Gobel U, Wahn U, Paul K. Sequential genotyping of Pseudomonas aeruginosa from upper and lower airways of cystic fibrosis patients. Eur Respir J 2002;20:1457-1463.
111. Aaron SD, Kottachchi D, Ferris WJ, Vandemheen KL, St Denis ML, Plouffe A, Doucette SP, Saginur R, Chan FT, Ramotar K. Sputum versus bronchoscopy for diagnosis of pseudomonas aeruginosa biofilms in cystic fibrosis. Eur Respir J 2004;24:631-637.
112. Armstrong DS, Grimwood K, Carlin JB, Carzino R, Olinsky A, Phelan PD. Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis. Pediatr Pulmonol 1996;21:267-275.
113. Rosenfeld M, Emerson J, Accurso F, Armstrong D, Castile R, Grimwood K, Hiatt P, McCoy K, McNamara S, Ramsey B, et al. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol 1999;28:321-328.
114. Burns JL, Gibson RL, McNamara S, Yim D, Emerson J, Rosenfeld M, Hiatt P, McCoy K, Castile R, Smith AL, et al. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis 2001;183:444-452.
115. Nixon GM, Armstrong DS, Carzino R, Carlin JB, Olinsky A, Robertson CF, Grimwood K. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr 2001;138:699-704.
116. Nixon GM, Armstrong DS, Carzino R, Carlin JB, Olinsky A, Robertson CF, Grimwood K, Wainwright C. Early airway infection, inflammation, and lung function in cystic fibrosis. Arch Dis Child 2002;87:306-311.
117. Armstrong DS, Hook SM, Jamesen KM, Nixon GM, Carzino R, Carlin JB, Robertson CF, Grimwood K. Lower airway inflammation in infants with cystic fibrosis detected by newborn screening. Pediatr Pulmonol 2005;40:500-510.
118. Hilliard TN, Sukhani S, Francis J, Madden N, Rosenthal M, Balfour-Lynn I, Bush A, Davies J. Bronchoscopy following diagnosis with cystic fibrosis. Arch Dis Child 2006 [Epub ahead of print, Nov 6]
119. Wainwright C, Carline J, Cooper P, Byrnes C, Dakin C, Whitehead B, Carter R, Vidmar S, Cheney J, Tiddens H, et al. Australian cystic fibrosis BAL study interim analysis. Pediatr Pulmonol 2006;(Suppl 29):A313.
120. Kettle AJ, Chan T, Osberg I, Senthilmohan R, Chapman AL, Mocatta TJ, Wagener JS. Myeloperoxidase and protein oxidation in the airways of young children with cystic fibrosis. Am J Respir Crit Care Med 2004;170:1317-1323.
121. Rosenfeld M, Gibson R, McNamara S, Emerson J, McCoy KS, Shell R, Borowitz D, Konstan MW, Retsch-Bogart G, Wilmott RW, et al. Serum and lower respiratory tract drug concentrations after tobramycin inhalation in young children with cystic fibrosis. J Pediatr 2001;139:572-577.
122. Wagener JS, Rock MJ, McCubbin MM, Hamilton SD, Johnson CA, Ahrens RC. Aerosol delivery and safety of recombinant human deoxyribonuclease in young children with cystic fibrosis: a bronchoscopic study. Pulmozyme Pediatric Bronchoscopy Study Group. J Pediatr 1998;133:486-491.
123. Gibson RL, Emerson J, McNamara S, Burns JL, Rosenfeld M, Yunker A, Hamblett N, Accurso F, Dovey M, Hiatt P, et al.; Cystic Fibrosis Therapeutic Development Network Study Group. Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis. Am J Respir Crit Care Med 2003;167:841-849.
124. Gutierrez JP, Grimwood K, Armstrong DS, Carlin JB, Carzino R, Olinsky A, Robertson CF, Phelan PD. Interlobar differences in bronchoalveolar lavage fluid from children with cystic fibrosis. Eur Respir J 2001;17:281-286.
125. Meyer KC, Sharma A. Regional variability of lung inflammation in cystic fibrosis. Am J Respir Crit Care Med 1997;156:1536-1540.
126. Wainwright C. Bronchoalveolar lavage to guide management of lung disease in children with cystic fibrosis. Pediatr Pulmonol 2006;(Suppl 29):S18.3.
127. Rabin HR, Butler SM, Wohl ME, Geller DE, Colin AA, Schidlow DV, Johnson CA, Konstan MW, Regelmann WE; Epidemiologic Study of Cystic Fibrosis. Pulmonary exacerbations in cystic fibrosis. Pediatr Pulmonol 2004;37:400-406.